Pretransplant free fatty acids (FFA) and allograft survival in renal transplantation1

Aaron C. Baker, Angelo M DeMattos, Steven Watkins, J. Bruce German, Christoph Troppmann, Richard V Perez

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Fatty acids and their eicosanoid metabolites have been shown to be important mediators of the immune response in transplantation. We hypothesize that elevated pretransplant free fatty acids (FFA) levels may be associated with prolonged survival of kidney transplants. Methods: Archived pretransplant sera of 130 patients who received a kidney transplant from 1991 to 1997 were analyzed by gas liquid chromatography for a comprehensive FFA profile. FFA levels were categorized by quartiles, and the association between quartiles of the levels for each free-fatty acid and graft survival was initially screened by serial univariate analyses (Kaplan-Meier). All significant variables (FFAs and transplant-specific risk factors) were entered into a multivariable (Cox regression) model. Results: With >10 y of follow-up, 68 kidney allografts were lost. Factors associated with decreased graft survival by univariate analysis included delayed graft function (DGF), acute rejection (AR), and cold ischemic time (CIT) >24 h. High levels of arachidonic and γ-linolenic FFA were associated with higher graft survival rates. By multivariate analysis, only DGF, AR, CIT, and arachidonic acid levels were significant. The odds ratios for graft failure for the highest, third, and second quartiles of the pretransplant level of arachidonic acid, compared with the lowest quartile, were 0.18, 0.32, and 0.64, respectively(P = 0.050, log-rank test). For arachidonic acid the survival benefit appeared to be graded with the highest quartile associated with a greater than 80% reduction of risk of kidney graft failure. Conclusion: Pretransplant level of arachidonic acid was independently associated with higher kidney graft survival rates. Further studies are necessary to identify the underlying mechanisms and to determine whether interventions aimed at increasing pretransplant arachidonic acid levels might prove beneficial for renal transplant outcomes.

Original languageEnglish (US)
Pages (from-to)182-187
Number of pages6
JournalJournal of Surgical Research
Volume164
Issue number2
DOIs
StatePublished - Dec 2010

Fingerprint

Nonesterified Fatty Acids
Allografts
Arachidonic Acid
Graft Survival
Transplants
Kidney
Delayed Graft Function
Cold Ischemia
Survival Rate
Eicosanoids
Kaplan-Meier Estimate
Risk Reduction Behavior
Survival Analysis
Proportional Hazards Models
Gas Chromatography
Renal Insufficiency
Fatty Acids
Multivariate Analysis
Transplantation
Odds Ratio

Keywords

  • arachidonic acid
  • eicosanoids
  • free fatty acids
  • kidney transplant
  • renal allograft survival
  • renal transplant

ASJC Scopus subject areas

  • Surgery

Cite this

Pretransplant free fatty acids (FFA) and allograft survival in renal transplantation1 . / Baker, Aaron C.; DeMattos, Angelo M; Watkins, Steven; German, J. Bruce; Troppmann, Christoph; Perez, Richard V.

In: Journal of Surgical Research, Vol. 164, No. 2, 12.2010, p. 182-187.

Research output: Contribution to journalArticle

@article{b29fa55527b54c8e98c4c1a9355be249,
title = "Pretransplant free fatty acids (FFA) and allograft survival in renal transplantation1",
abstract = "Background: Fatty acids and their eicosanoid metabolites have been shown to be important mediators of the immune response in transplantation. We hypothesize that elevated pretransplant free fatty acids (FFA) levels may be associated with prolonged survival of kidney transplants. Methods: Archived pretransplant sera of 130 patients who received a kidney transplant from 1991 to 1997 were analyzed by gas liquid chromatography for a comprehensive FFA profile. FFA levels were categorized by quartiles, and the association between quartiles of the levels for each free-fatty acid and graft survival was initially screened by serial univariate analyses (Kaplan-Meier). All significant variables (FFAs and transplant-specific risk factors) were entered into a multivariable (Cox regression) model. Results: With >10 y of follow-up, 68 kidney allografts were lost. Factors associated with decreased graft survival by univariate analysis included delayed graft function (DGF), acute rejection (AR), and cold ischemic time (CIT) >24 h. High levels of arachidonic and γ-linolenic FFA were associated with higher graft survival rates. By multivariate analysis, only DGF, AR, CIT, and arachidonic acid levels were significant. The odds ratios for graft failure for the highest, third, and second quartiles of the pretransplant level of arachidonic acid, compared with the lowest quartile, were 0.18, 0.32, and 0.64, respectively(P = 0.050, log-rank test). For arachidonic acid the survival benefit appeared to be graded with the highest quartile associated with a greater than 80{\%} reduction of risk of kidney graft failure. Conclusion: Pretransplant level of arachidonic acid was independently associated with higher kidney graft survival rates. Further studies are necessary to identify the underlying mechanisms and to determine whether interventions aimed at increasing pretransplant arachidonic acid levels might prove beneficial for renal transplant outcomes.",
keywords = "arachidonic acid, eicosanoids, free fatty acids, kidney transplant, renal allograft survival, renal transplant",
author = "Baker, {Aaron C.} and DeMattos, {Angelo M} and Steven Watkins and German, {J. Bruce} and Christoph Troppmann and Perez, {Richard V}",
year = "2010",
month = "12",
doi = "10.1016/j.jss.2010.07.038",
language = "English (US)",
volume = "164",
pages = "182--187",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Pretransplant free fatty acids (FFA) and allograft survival in renal transplantation1

AU - Baker, Aaron C.

AU - DeMattos, Angelo M

AU - Watkins, Steven

AU - German, J. Bruce

AU - Troppmann, Christoph

AU - Perez, Richard V

PY - 2010/12

Y1 - 2010/12

N2 - Background: Fatty acids and their eicosanoid metabolites have been shown to be important mediators of the immune response in transplantation. We hypothesize that elevated pretransplant free fatty acids (FFA) levels may be associated with prolonged survival of kidney transplants. Methods: Archived pretransplant sera of 130 patients who received a kidney transplant from 1991 to 1997 were analyzed by gas liquid chromatography for a comprehensive FFA profile. FFA levels were categorized by quartiles, and the association between quartiles of the levels for each free-fatty acid and graft survival was initially screened by serial univariate analyses (Kaplan-Meier). All significant variables (FFAs and transplant-specific risk factors) were entered into a multivariable (Cox regression) model. Results: With >10 y of follow-up, 68 kidney allografts were lost. Factors associated with decreased graft survival by univariate analysis included delayed graft function (DGF), acute rejection (AR), and cold ischemic time (CIT) >24 h. High levels of arachidonic and γ-linolenic FFA were associated with higher graft survival rates. By multivariate analysis, only DGF, AR, CIT, and arachidonic acid levels were significant. The odds ratios for graft failure for the highest, third, and second quartiles of the pretransplant level of arachidonic acid, compared with the lowest quartile, were 0.18, 0.32, and 0.64, respectively(P = 0.050, log-rank test). For arachidonic acid the survival benefit appeared to be graded with the highest quartile associated with a greater than 80% reduction of risk of kidney graft failure. Conclusion: Pretransplant level of arachidonic acid was independently associated with higher kidney graft survival rates. Further studies are necessary to identify the underlying mechanisms and to determine whether interventions aimed at increasing pretransplant arachidonic acid levels might prove beneficial for renal transplant outcomes.

AB - Background: Fatty acids and their eicosanoid metabolites have been shown to be important mediators of the immune response in transplantation. We hypothesize that elevated pretransplant free fatty acids (FFA) levels may be associated with prolonged survival of kidney transplants. Methods: Archived pretransplant sera of 130 patients who received a kidney transplant from 1991 to 1997 were analyzed by gas liquid chromatography for a comprehensive FFA profile. FFA levels were categorized by quartiles, and the association between quartiles of the levels for each free-fatty acid and graft survival was initially screened by serial univariate analyses (Kaplan-Meier). All significant variables (FFAs and transplant-specific risk factors) were entered into a multivariable (Cox regression) model. Results: With >10 y of follow-up, 68 kidney allografts were lost. Factors associated with decreased graft survival by univariate analysis included delayed graft function (DGF), acute rejection (AR), and cold ischemic time (CIT) >24 h. High levels of arachidonic and γ-linolenic FFA were associated with higher graft survival rates. By multivariate analysis, only DGF, AR, CIT, and arachidonic acid levels were significant. The odds ratios for graft failure for the highest, third, and second quartiles of the pretransplant level of arachidonic acid, compared with the lowest quartile, were 0.18, 0.32, and 0.64, respectively(P = 0.050, log-rank test). For arachidonic acid the survival benefit appeared to be graded with the highest quartile associated with a greater than 80% reduction of risk of kidney graft failure. Conclusion: Pretransplant level of arachidonic acid was independently associated with higher kidney graft survival rates. Further studies are necessary to identify the underlying mechanisms and to determine whether interventions aimed at increasing pretransplant arachidonic acid levels might prove beneficial for renal transplant outcomes.

KW - arachidonic acid

KW - eicosanoids

KW - free fatty acids

KW - kidney transplant

KW - renal allograft survival

KW - renal transplant

UR - http://www.scopus.com/inward/record.url?scp=78449284610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449284610&partnerID=8YFLogxK

U2 - 10.1016/j.jss.2010.07.038

DO - 10.1016/j.jss.2010.07.038

M3 - Article

C2 - 20855086

AN - SCOPUS:78449284610

VL - 164

SP - 182

EP - 187

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -